Metro Healthcare Indonesia Cash Flow Reinvestment Rate

Latest as of September 2025: 0.11x

Metro Healthcare Indonesia cash flow reinvestment rate. Metro Healthcare Indonesia (CARE) has a Cash Flow Reinvestment Rate of 0.11x as of September 2025, reinvesting Rp1.77 Billion (capex Rp1.77 Billion ) from operating cash flow of Rp16.50 Billion. Explore Metro Healthcare Indonesia cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.11x
(Capex + Investments) / Operating CF

Total Reinvested

Rp1.77 Billion
Capex + Investments

Operating Cash Flow

Rp16.50 Billion
IDR

Capital Expenditures

Rp1.77 Billion
IDR

Cash Flow Reinvestment Rate of Metro Healthcare Indonesia (2020–2021)

Cash flow reinvestment rate of Metro Healthcare Indonesia from 2020 to 2021. Historical reinvestment intensity for Metro Healthcare Indonesia across 2 annual periods. Explore capital reinvestment ratio of Metro Healthcare Indonesia to see what proportion of operating cash flow is directed to capital expenditures.

Metro Healthcare Indonesia Cash Flow Reinvestment Rate by Year (2020–2021)

Metro Healthcare Indonesia cash flow reinvestment rate by year from 2020 to 2021. Year-by-year capital reinvestment analysis for Metro Healthcare Indonesia. For the full cash flow conversion analysis, see CARE cash flow metrics.

Year Reinvestment Rate Total Reinvested (IDR) Operating CF Capex YoY Change
2021 16.13x Rp760.40 Billion Rp47.13 Billion Rp310.40 Billion ▲ +49.7%
2020 10.78x Rp542.27 Billion Rp50.30 Billion Rp522.27 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow